Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
GlobeNewswire
Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports..
Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports..
Last month, a Florida jury awarded more than $260 million in damages and punitive damages to the family of Maya Kowalski, a..
Up to $50,000 in potential awards for pediatric medical devices created by Hispanic and African American..